It has been established that VEGF-B primarily interacts with Flt-1 (vascular endothelial growth factor receptor) and sFlt-1 (soluble vascular endothelial growth factor receptor-2) and inhibits vascular endothelial dysfunction in preeclampsia. The gene discussed is FLT1; the disease is preeclampsia.